“In Vivo Delivery of Nucleic Acid-Formulated Microparticles As a Potential Tolerogenic Vaccine for Type 1 Diabetes ”. The Review of Diabetic Studies 9, no. 4 (August 12, 2023). Accessed September 13, 2025. https://diabeticstudies.org/index.php/RDS/article/view/184.